If you have undergone stenting to improve blood flow through your coronary arteries, you likely have been prescribed dual anti-platelet therapy, or DAPT. It’s a two-drug regimen consisting of aspirin plus a P2Y12 inhibitor—clopidogrel (Plavix®), ticagrelor (Brilinta®) or prasugrel (Effient®). DAPT prevents blood clots from forming inside a stent.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
